Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CURIS, INC.
Curis Doses First Five Patients in TakeAim CLL Study
July 30, 2026
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
June 26, 2026
Curis Provides First Quarter 2026 Business Update
May 21, 2026
Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026
May 6, 2026
Curis Provides Fourth Quarter 2025 Business Update
May 1, 2026
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
April 29, 2026